A Phase 1/2, Open-Label, Multicenter Study of Isatuximab in Combination with Cemiplimab in Patients with Lymphoma
Carmelo Carlo-Stella,Pier Luigi Zinzani,Anna Sureda,Luis Araujo,Olivier Casasnovas,Cecilia Carpio,Su-Peng Yeh,Krimo Bouabdallah,Guillaume Cartron,Won Seog Kim,Raul Cordoba,Youngil Koh,Alessandro Re,Daniela Alves,Martine Chamuleau,Steven Le Gouill,Armando Lopez-Guillermo,Ilidia Moreira,Marjolein W. M. van der Poel,Giovanni Abbadessa,Robin Meng, Ran Ji,Lucie Lepine,Rao Saleem,Vincent Ribrag HEMATOLOGICAL ONCOLOGY（2023）
AI 理解论文
溯源树
样例
